Cargando…

Insulin-like growth factor-1 stimulates regulatory T cells and suppresses autoimmune disease

The recent precipitous rise in autoimmune diseases is placing an increasing clinical and economic burden on health systems worldwide. Current therapies are only moderately efficacious, often coupled with adverse side effects. Here, we show that recombinant human insulin-like growth factor-1 (rhIGF-1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bilbao, Daniel, Luciani, Luisa, Johannesson, Bjarki, Piszczek, Agnieszka, Rosenthal, Nadia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237469/ https://www.ncbi.nlm.nih.gov/pubmed/25339185 http://dx.doi.org/10.15252/emmm.201303376

Ejemplares similares

Insulin-like growth factor-1 induces regulatory T cell-mediated suppression of allergic contact dermatitis in mice
por: Johannesson, Bjarki, et al.
Publicado: (2014)

Insulin-Like Growth Factor Binding Proteins in Autoimmune Diseases
por: Ding, Huihua, et al.
Publicado: (2018)

Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice
por: Barton, Elisabeth R., et al.
Publicado: (2002)

NKTR-358: A novel regulatory T-cell stimulator that selectively stimulates expansion and suppressive function of regulatory T cells for the treatment of autoimmune and inflammatory diseases
por: Dixit, Neha, et al.
Publicado: (2021)

Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factor-binding Proteins in Ovarian Cancer
por: Amutha, Periyasamy, et al.
Publicado: (2017)

Histamine-stimulated expression of insulin-like growth factors in human glioma cells.
por: Van der Ven, L. T., et al.
Publicado: (1997)

Insulin-Like Growth Factor (IGF) System in Liver Diseases
por: Adamek, Agnieszka, et al.
Publicado: (2018)

Tumour suppression associated with expression of human insulin-like growth factor II.
por: Schofield, P. N., et al.
Publicado: (1991)

Insulin and Insulin‐like Growth Factor 1 Stimulate Proliferation of Metastatic Variants of Colon Carcinoma 26
por: Koenuma, Mitsuo, et al.
Publicado: (1989)

IGFBP-3 promotes cachexia-associated lipid loss by suppressing insulin-like growth factor/insulin signaling
por: Wang, Xiaohui, et al.
Publicado: (2003)

Gut Microbiota and Bacterial DNA Suppress Autoimmunity by Stimulating Regulatory B Cells in a Murine Model of Lupus
por: Mu, Qinghui, et al.
Publicado: (2020)

Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function
por: Marshman, Emma, et al.
Publicado: (2002)

The Role of Insulin-Like Growth Factors and Insulin-Like Growth Factor–Binding Proteins in the Nervous System
por: Lewitt, Moira S, et al.
Publicado: (2019)

Co-stimulation of gastrointestinal tumour cell growth by gastrin, transforming growth factor alpha and insulin like growth factor-I.
por: Durrant, L. G., et al.
Publicado: (1991)

Systemic Toll-Like Receptor Stimulation Suppresses Experimental Allergic Asthma and Autoimmune Diabetes in NOD Mice
por: Aumeunier, Aude, et al.
Publicado: (2010)

Neuroprotective astrocyte-derived insulin/insulin-like growth factor 1 stimulates endocytic processing and extracellular release of neuron-bound Aβ oligomers
por: Pitt, Jason, et al.
Publicado: (2017)

The Insulin-Like Growth Factor System
por: Roith, Derek Le
Publicado: (2003)

Insulin-like growth factors and cancer.
por: Macaulay, V. M.
Publicado: (1992)

Effects of suppressing bioavailability of insulin‐like growth factor on age‐associated intervertebral disc degeneration
por: Kritschil, Rebecca, et al.
Publicado: (2020)

CFTR Regulates Early Pathogenesis of Chronic Obstructive Lung Disease in βENaC-Overexpressing Mice
por: Johannesson, Bjarki, et al.
Publicado: (2012)

In silico interaction of insulin-like growth factor binding protein 3 with insulin-like growth factor 1
por: Jafari, Elham, et al.
Publicado: (2018)

E-Peptides Control Bioavailability of IGF-1
por: Hede, Marianne Smedegaard, et al.
Publicado: (2012)

Quantitative analysis of insulin-like growth factor 2 receptor and insulin-like growth factor binding proteins to identify control mechanisms for insulin-like growth factor 1 receptor phosphorylation
por: Tian, Dan, et al.
Publicado: (2016)

Impaired Genome Maintenance Suppresses the Growth Hormone–Insulin-Like Growth Factor 1 Axis in Mice with Cockayne Syndrome
por: van der Pluijm, Ingrid, et al.
Publicado: (2007)

How insulin-like growth factor I binds to a hybrid insulin receptor type 1 insulin-like growth factor receptor
por: Xu, Yibin, et al.
Publicado: (2022)

Investigation of insulin-like growth factors/insulin-like growth factor binding proteins regulation in metabolic syndrome patients
por: Pouriamehr, Somayeh, et al.
Publicado: (2019)

The Insight into Insulin-Like Growth Factors and Insulin-Like Growth-Factor-Binding Proteins and Metabolic Profile in Pediatric Obesity
por: Czogała, Wojciech, et al.
Publicado: (2021)

Insulin-Like Growth Factor-Binding Proteins of Teleost Fishes
por: Garcia de la Serrana, Daniel, et al.
Publicado: (2018)

In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes
por: Tang, Qizhi, et al.
Publicado: (2004)

Suppression of lethal autoimmunity by regulatory T cells with a single TCR specificity
por: Levine, Andrew G., et al.
Publicado: (2017)

NAC1 modulates autoimmunity by suppressing regulatory T cell–mediated tolerance
por: Yang, Jin-Ming, et al.
Publicado: (2022)

Combined treatment with electrical stimulation and insulin-like growth factor-1 promotes bone regeneration in vitro
por: Qi, Zhiping, et al.
Publicado: (2018)

Insulin-like growth factor 1 stimulates the angiogenic activity of adipose tissue–derived microvascular fragments
por: Laschke, Matthias W, et al.
Publicado: (2019)

Insulin-like growth factor-1 endues monocytes with immune suppressive ability to inhibit inflammation in the intestine
por: Ge, Rong-Ti, et al.
Publicado: (2015)

LINC00052 suppressed glioma cell proliferation and invasion by downregulating insulin-like growth factor 2
por: Piao, Yinzi, et al.
Publicado: (2019)

Targeting insulin-like growth factor pathways
por: Yee, D
Publicado: (2006)

Insulin-like growth factors: the unrecognised oncogenes.
por: Westley, B. R., et al.
Publicado: (1995)

Insulin-Like Growth Factor-1 and Neuroinflammation
por: Labandeira-Garcia, Jose L., et al.
Publicado: (2017)

Insulin-Like Growth Factor Pathway and the Thyroid
por: Smith, Terry J.
Publicado: (2021)

Insulin, insulin-like growth factor 1 and insulin-like growth factor binding protein 3 serum concentrations in patients with adenomatous colon polyps
por: Janiak, Adam, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_91tb3i85c0ga05lv64l72k8f0v